1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
Yamamoto, A.; Takagishi, K.; Osawa, T.; Yanagawa, T.; Nakajima, D.; Shitara, H.; Kobayashi, T. Prevalence and risk factors of a
rotator cuff tear in the general population. J. Shoulder Elb. Surg. 2010, 19, 116–120. [CrossRef] [PubMed]
Abboud, J.A.; Kim, J.S. The effect of hypercholesterolemia on rotator cuff disease. Clin. Orthop. Relat. Res. 2010, 468, 1493–1497.
[CrossRef] [PubMed]
McDermott, F.T. Repetition strain injury: A review of current understanding. Med. J. Aust. 1986, 144, 196–200. [CrossRef]
[PubMed]
Jahan, H.; Choudhary, M.I. Glycation, carbonyl stress and AGEs inhibitors: A patent review. Expert Opin. Ther. Pat. 2015, 25,
1267–1284. [PubMed]
Stinghen, A.E.; Massy, Z.A.; Vlassara, H.; Striker, G.E.; Boullier, A. Uremic Toxicity of Advanced Glycation End Products in CKD.
J. Am. Soc. Nephrol. 2016, 27, 354–370. [CrossRef] [PubMed]
Saito, M.; Marumo, K. Collagen cross-links as a determinant of bone quality: A possible explanation for bone fragility in aging,
osteoporosis, and diabetes mellitus. Osteoporos. Int. 2010, 21, 195–214. [CrossRef]
Remigante, A.; Spinelli, S.; Basile, N.; Caruso, D.; Falliti, G.; Dossena, S.; Marino, A.; Morabito, R. Oxidation Stress as a Mechanism
of Aging in Human Erythrocytes: Protective Effect of Quercetin. Int. J. Mol. Sci. 2022, 23, 7791. [CrossRef]
Moldogazieva, N.T.; Mokhosoev, I.M.; Mel’nikova, T.I.; Porozov, Y.B.; Terentiev, A.A. Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases. Oxidative Med. Cell. Longev. 2019,
2019, 3085756. [CrossRef]
Fuentealba, D.; Friguet, B.; Silva, E. Advanced glycation endproducts induce photocrosslinking and oxidation of bovine lens
proteins through type-I mechanism. Photochem. Photobiol. 2009, 85, 185–194. [CrossRef]
Yan, H.D.; Li, X.Z.; Xie, J.M.; Li, M. Effects of advanced glycation end products on renal fibrosis and oxidative stress in cultured
NRK-49F cells. Chin. Med. J. 2007, 120, 787–793. [CrossRef]
Grossin, N.; Auger, F.; Niquet-Leridon, C.; Durieux, N.; Montaigne, D.; Schmidt, A.M.; Susen, S.; Jacolot, P.; Beuscart, J.B.; Tessier,
F.J.; et al. Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice. Mol. Nutr. Food
Res. 2015, 59, 927–938. [CrossRef] [PubMed]
Ahmad, S.; Siddiqui, Z.; Rehman, S.; Khan, M.Y.; Khan, H.; Khanum, S.; Alouffi, S.; Saeed, M. A Glycation Angle to Look into the
Diabetic Vasculopathy: Cause and Cure. Curr. Vasc. Pharmacol. 2017, 15, 352–364. [CrossRef] [PubMed]
Basta, G. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.
Atherosclerosis 2008, 196, 9–21. [CrossRef] [PubMed]
Brown, S.M.; Smith, D.M.; Alt, N.; Thorpe, S.R.; Baynes, J.W. Tissue-specific variation in glycation of proteins in diabetes: Evidence
for a functional role of amadoriase enzymes. Ann. N. Y. Acad. Sci. 2005, 1043, 817–823. [CrossRef] [PubMed]
Shakeel, M. Recent advances in understanding the role of oxidative stress in diabetic neuropathy. Diabetes Metab. Syndr. 2015, 9,
373–378. [CrossRef] [PubMed]
Portal-Nunez, S.; Ardura, J.A.; Lozano, D.; Martinez de Toda, I.; De la Fuente, M.; Herrero-Beaumont, G.; Largo, R.; Esbrit, P.
Parathyroid hormone-related protein exhibits antioxidant features in osteoblastic cells through its N-terminal and osteostatin
domains. Bone Jt. Res. 2018, 7, 58–68. [CrossRef] [PubMed]
Jin, L.; Lagoda, G.; Leite, R.; Webb, R.C.; Burnett, A.L. NADPH oxidase activation: A mechanism of hypertension-associated
erectile dysfunction. J. Sex. Med. 2008, 5, 544–551. [CrossRef]
Taye, A.; Saad, A.H.; Kumar, A.H.; Morawietz, H. Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS
pathway in human endothelial cells exposed to high glucose. Eur. J. Pharmacol. 2010, 627, 42–48. [CrossRef]
Mifune, Y.; Inui, A.; Muto, T.; Nishimoto, H.; Kataoka, T.; Kurosawa, T.; Yamaura, K.; Mukohara, S.; Niikura, T.; Kokubu, T.; et al.
Influence of advanced glycation end products on rotator cuff. J. Shoulder Elb. Surg. 2019, 28, 1490–1496. [CrossRef]
Heumuller, S.; Wind, S.; Barbosa-Sicard, E.; Schmidt, H.H.; Busse, R.; Schroder, K.; Brandes, R.P. Apocynin is not an inhibitor of
vascular NADPH oxidases but an antioxidant. Hypertension 2008, 51, 211–217. [CrossRef]
Gimenes, R.; Gimenes, C.; Rosa, C.M.; Xavier, N.P.; Campos, D.H.S.; Fernandes, A.A.H.; Cezar, M.D.M.; Guirado, G.N.; Pagan,
L.U.; Chaer, I.D.; et al. Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus.
Cardiovasc. Diabetol. 2018, 17, 15. [CrossRef] [PubMed]
Yokota, T.; Kinugawa, S.; Hirabayashi, K.; Matsushima, S.; Inoue, N.; Ohta, Y.; Hamaguchi, S.; Sobirin, M.A.; Ono, T.; Suga, T.; et al.
Oxidative stress in skeletal muscle impairs mitochondrial respiration and limits exercise capacity in type 2 diabetic mice. Am. J.
Physiol. Heart Circ. Physiol. 2009, 297, H1069–H1077. [CrossRef] [PubMed]
Curr. Issues Mol. Biol. 2023, 45
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
3445
Sanchez-Duarte, S.; Montoya-Perez, R.; Marquez-Gamino, S.; Vera-Delgado, K.S.; Caudillo-Cisneros, C.; Sotelo-Barroso, F.;
Sanchez-Briones, L.A.; Sanchez-Duarte, E. Apocynin Attenuates Diabetes-Induced Skeletal Muscle Dysfunction by Mitigating
ROS Generation and Boosting Antioxidant Defenses in Fast-Twitch and Slow-Twitch Muscles. Life 2022, 12, 674. [CrossRef]
[PubMed]
Legerlotz, K.; Riley, G.P.; Screen, H.R. Specimen dimensions influence the measurement of material properties in tendon fascicles.
J. Biomech. 2010, 43, 2274–2280. [CrossRef]
Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414, 813–820. [CrossRef]
Hancock, J.T.; Desikan, R.; Neill, S.J. Role of reactive oxygen species in cell signalling pathways. Biochem. Soc. Trans. 2001, 29,
345–350. [CrossRef]
Sumimoto, H. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J.
2008, 275, 3249–3277. [CrossRef]
Koike, S.; Yano, S.; Tanaka, S.; Sheikh, A.M.; Nagai, A.; Sugimoto, T. Advanced Glycation End-Products Induce Apoptosis of
Vascular Smooth Muscle Cells: A Mechanism for Vascular Calcification. Int. J. Mol. Sci. 2016, 17, 1567. [CrossRef]
Ueda, Y.; Inui, A.; Mifune, Y.; Sakata, R.; Muto, T.; Harada, Y.; Takase, F.; Kataoka, T.; Kokubu, T.; Kuroda, R. The effects of high
glucose condition on rat tenocytes in vitro and rat Achilles tendon in vivo. Bone Jt. Res. 2018, 7, 362–372. [CrossRef]
Ott, C.; Jacobs, K.; Haucke, E.; Navarrete Santos, A.; Grune, T.; Simm, A. Role of advanced glycation end products in cellular
signaling. Redox Biol. 2014, 2, 411–429. [CrossRef]
Olukman, M.; Orhan, C.E.; Celenk, F.G.; Ulker, S. Apocynin restores endothelial dysfunction in streptozotocin diabetic rats
through regulation of nitric oxide synthase and NADPH oxidase expressions. J. Diabetes Complicat. 2010, 24, 415–423. [CrossRef]
[PubMed]
Thallas-Bonke, V.; Thorpe, S.R.; Coughlan, M.T.; Fukami, K.; Yap, F.Y.; Sourris, K.C.; Penfold, S.A.; Bach, L.A.; Cooper, M.E.;
Forbes, J.M. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy
through a protein kinase C-alpha-dependent pathway. Diabetes 2008, 57, 460–469. [CrossRef] [PubMed]
Mahali, S.; Raviprakash, N.; Raghavendra, P.B.; Manna, S.K. Advanced glycation end products (AGEs) induce apoptosis via
a novel pathway: Involvement of Ca2+ mediated by interleukin-8 protein. J. Biol. Chem. 2011, 286, 34903–34913. [CrossRef]
[PubMed]
Kaushal, N.; Bansal, M.P. Dietary selenium variation-induced oxidative stress modulates CDC2/cyclin B1 expression and
apoptosis of germ cells in mice testis. J. Nutr. Biochem. 2007, 18, 553–564. [CrossRef] [PubMed]
Tang, X.Y.; Zhang, Q.; Dai, D.Z.; Ying, H.J.; Wang, Q.J.; Dai, Y. Effects of strontium fructose 1,6-diphosphate on expression of
apoptosis-related genes and oxidative stress in testes of diabetic rats. Int. J. Urol. 2008, 15, 251–256. [CrossRef]
Yuan, J.; Murrell, G.A.; Trickett, A.; Landtmeters, M.; Knoops, B.; Wang, M.X. Overexpression of antioxidant enzyme peroxiredoxin
5 protects human tendon cells against apoptosis and loss of cellular function during oxidative stress. Biochim. Biophys. Acta 2004,
1693, 37–45. [CrossRef]
Li, M.; Liu, Z.; Zhuan, L.; Wang, T.; Guo, S.; Wang, S.; Liu, J.; Ye, Z. Effects of apocynin on oxidative stress and expression of
apoptosis-related genes in testes of diabetic rats. Mol. Med. Rep. 2013, 7, 47–52. [CrossRef]
Kameyama, M.; Chen, K.R.; Mukai, K.; Shimada, A.; Atsumi, Y.; Yanagimoto, S. Histopathological characteristics of stenosing
flexor tenosynovitis in diabetic patients and possible associations with diabetes-related variables. J. Hand Surg. Am 2013, 38,
1331–1339. [CrossRef]
Tsai, W.C.; Liang, F.C.; Cheng, J.W.; Lin, L.P.; Chang, S.C.; Chen, H.H.; Pang, J.H. High glucose concentration up-regulates the
expression of matrix metalloproteinase-9 and -13 in tendon cells. BMC Musculoskelet. Disord. 2013, 14, 255. [CrossRef]
Kislinger, T.; Fu, C.; Huber, B.; Qu, W.; Taguchi, A.; Du Yan, S.; Hofmann, M.; Yan, S.F.; Pischetsrieder, M.; Stern, D.; et al.
N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate
cell signaling pathways and modulate gene expression. J. Biol. Chem. 1999, 274, 31740–31749. [CrossRef]
Oreff, G.L.; Fenu, M.; Vogl, C.; Ribitsch, I.; Jenner, F. Species variations in tenocytes’ response to inflammation require careful
selection of animal models for tendon research. Sci. Rep. 2021, 11, 12451. [CrossRef] [PubMed]
Goh, S.Y.; Cooper, M.E. Clinical review: The role of advanced glycation end products in progression and complications of diabetes.
J. Clin. Endocrinol. Metab. 2008, 93, 1143–1152. [CrossRef] [PubMed]
Yao, L.; Bestwick, C.S.; Bestwick, L.A.; Maffulli, N.; Aspden, R.M. Phenotypic drift in human tenocyte culture. Tissue Eng. 2006,
12, 1843–1849. [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual
author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to
people or property resulting from any ideas, methods, instructions or products referred to in the content.
...